Robustness of 4D-optimized intensity-modulated proton radiation therapy and proton arc radiation therapy for stereotactic arrhythmia radio-ablation against cardiorespiratory motion

Developing an accurate model of spot-scanning treatment delivery time and sequence for a compact superconducting synchrocyclotron proton therapy system

10.1186/s13014-022-02055-w · doi-reference

Electrocardiogram-gated cardiac computed tomography-based patient- and segment-specific cardiac motion estimation method in stereotactic arrhythmia radioablation for ventricular tachycardia

10.1016/j.phro.2025.100700 · doi-reference

Proton or photon radiosurgery for cardiac ablation of ventricular tachycardia? Breath and ECG gated robust optimization

10.1016/j.ejmp.2020.08.021 · doi-reference

Mitigation of the interplay effects of combining 4D robust with layer repainting techniques in proton-based SBRT for patients with early-stage non-small cell lung cancer

10.3389/fonc.2020.574605 · doi-reference

A motion analysis of cardiac substructures for guiding stereotactic arrhythmia radiotherapy motion management

10.1002/mp.18115 · doi-reference

4D robust evaluation for the intensity-modulated-proton-radiotherapy plans for patients with ventricular tachycardia based on cardiopulmonary motion characteristics

10.1016/j.ejmp.2026.105790 · doi-reference

Analyzing cardiorespiratory motion and its dosimetric effect on stereotactic arrhythmia radio-ablation: A STOPSTORM.eu consortium study

10.1016/j.ijrobp.2025.09.039 · doi-reference

Stereotactic arrhythmia radioablation (STAR): Assessment of cardiac and respiratory heart motion in ventricular tachycardia patients - A STOPSTORM.eu consortium review

10.1016/j.radonc.2023.109844 · doi-reference

A framework for assessing the effect of cardiac and respiratory motion for stereotactic arrhythmia radioablation using a digital phantom with a 17-segment model: A STOPSTORM.eu consortium study

10.1016/j.ijrobp.2023.08.059 · doi-reference

4D XCAT phantom for multimodality imaging research

10.1118/1.3480985 · doi-reference

Population of anatomically variable 4D XCAT adult phantoms for imaging research and optimization

10.1118/1.4794178 · doi-reference

Phase I/II trial of electrophysiology-guided noninvasive cardiac radioablation for ventricular tachycardia

10.1161/circulationaha.118.038261 · doi-reference

Comprehensive 4D robustness evaluation for pencil beam scanned proton plans

10.1016/j.radonc.2019.03.037 · doi-reference

Left ventricle segment-specific motion assessment for cardiac-gated radiosurgery

10.1088/2057-1976/ad29a4 · doi-reference

Range uncertainties in proton therapy and the role of monte carlo simulations

10.1088/0031-9155/57/11/r99 · doi-reference

Effects of intrafractional motion on water equivalent pathlength in respiratory-gated heavy charged particle beam radiotherapy

10.1016/j.ijrobp.2007.05.018 · doi-reference

Stereotactic arrhythmia radioablation (STAR)—A systematic review and meta-analysis of prospective trials on behalf of the STOPSTORM.eu consortium

10.1016/j.hrthm.2024.07.029 · doi-reference

Evaluation of interplay and organ motion effects by means of 4D dose reconstruction and accumulation

10.1016/j.radonc.2020.07.055 · doi-reference

Quantifying dose uncertainties resulting from cardiorespiratory motion in intensity-modulated proton therapy for cardiac stereotactic body radiotherapy

10.1002/mp.17284 · doi-reference

Parameter based 4D dose calculations for proton therapy

10.1016/j.phro.2023.100473 · doi-reference

Scanned proton radiotherapy for mobile targets—The effectiveness of re-scanning in the context of different treatment planning approaches and for different motion characteristics

10.1088/0031-9155/56/22/016 · doi-reference

Motion interplay as a function of patient parameters and spot size in spot scanning proton therapy for lung cancer

10.1016/j.ijrobp.2013.01.024 · doi-reference

The role of cardiac imaging in heart failure with reduced ejection fraction

10.15420/cfr.2021.33 · doi-reference

Stereotactic arrhythmia radioablation for refractory scar-related ventricular tachycardia

10.1016/j.hrthm.2020.02.036 · doi-reference

Potential for improvements in robustness and optimality of intensity-modulated proton therapy for lung cancer with 4-dimensional robust optimization

10.3390/cancers11010035 · doi-reference

Minimax optimization for handling range and setup uncertainties in proton therapy

10.1118/1.3556559 · doi-reference

4D robust optimization including uncertainties in time structures can reduce the interplay effect in proton pencil beam scanning radiation therapy

10.1002/mp.13094 · doi-reference

First-in-man case of non-invasive proton radiotherapy for the treatment of refractory ventricular tachycardia in advanced heart failure

10.1002/ejhf.2056 · doi-reference

Spot-scanning proton arc (SPArc) therapy: The first robust and delivery-efficient spot-scanning proton arc therapy

10.1016/j.ijrobp.2016.08.049 · doi-reference

Risk of ischemic heart disease in women after radiotherapy for breast cancer

10.1056/nejmoa1209825 · doi-reference

Noninvasive cardiac radiation for ablation of ventricular tachycardia

10.1056/nejmoa1613773 · doi-reference

A dosimetric and robustness analysis of proton arc therapy with early energy layer and spot assignment for lung cancer versus conventional intensity modulated proton therapy

10.2340/1651-226x.2024.40549 · doi-reference

Moving beyond mean heart dose: The importance of cardiac substructures in radiation therapy toxicity

10.1111/1754-9485.13737 · doi-reference

Motion in radiotherapy: Particle therapy

10.1088/0031-9155/56/16/r01 · doi-reference

Stereotactic body radiation therapy: The report of AAPM task group 101

10.1118/1.3438081 · doi-reference

Cardiac toxicity of thoracic radiotherapy: Existing evidence and future directions

10.1016/j.jtho.2020.11.002 · doi-reference